First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

528 Reviews

Credit Rating - NIK PHARMA LIMITED

ANALYSIS
Credit Risk Update: SECURED CREDITOR INFORMATION: NIK PHARMA LIMITED, The Woodlands, Pwllmelin Lane, Cardiff, South Glamorgan, CF5 2NQ. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 30 November 2023. The company was incorporated on 17 November 2015.

The accounts next due date is 31 August 2025. There are 5 mortgages, 2 satisfied, none part satisfied and 3 unsatisfied.

The above was based on public record information as at 13 January 2025 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 09875397
Date Incorporated: 17 November 2015
Date Latest Accounts: 30 November 2023
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 09875397
Annual Return: Unknown
Registered Office: The Woodlands, Pwllmelin Lane, Cardiff, South Glamorgan, CF5 2NQ
SIC Code and Operations: 47730
SECURED CREDITORS
Number of Mortgages 5
Satisfied Mortgages 2
Part Satisfied Mortgages 0
Unsatisfied Mortgages 3
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

NIK PHARMA LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 23 January 2025 Copyright © 2025 First Report Ltd


Recent Searches

Reg No. Reg Name Status
09992131 NIK PHILLIPS CONSULTING LIMITED Active - Proposal to Strike off
10300273 NIK PROPERTIES LIMITED Active
14845001 NIK PROPERTY INVESTMENTS LTD Active
12776454 NIK PROPERTY LTD Active
14501875 NIK PROPERTY SERVICES LTD Active

In using this service you agree to the Terms and Conditions

© 2025 First Report Ltd